İyotlu Kontrast Madde ile Oluşan Endokrin Tablolar

Bourin M, Jolliet P. An overview of the clinical pharmacokinetics of x-ray contrast media. Clinical Pharmocokinetics. 1997;32(3):180-93.

Meurer K, Kelsch B, Hogstrom B. The pharmacokinetic profile, tolerability and safety of the iodinated, non-ionic, dimeric contrast medium Iosimenol 340 injection in healthy human subjects. Acta radyologica. 2015;56(5):581-86.

Geenen RW, Kingma HJ, van der Molen AJ. Contrast-induced nephropathy: pharmacology, pathophysiology and prevention. Insights Imaging. 2013;4(6):811-20.

Krause D, Marycz D, Ziada KM. Nonrenal Complications of Contrast Media. Interventional Cardiology Clinics. 2020;9(3):311-9.

Nielsen Y, Thomsen H. Trends in contrast media research the last 100 years. Acta radyologica. 2021;62(11):1515-24.

Wolff J, Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem. 1948;174(2):555-64.

Lee SY, Rhee CM, Leung AM, et al. A review: radiographic iodinated contrast media-induced thyroid dysfunction. The Journal of Clinical Endocrinology & Metabolism. 2015;100(2):376-83.

Wolff J, Chaikoff IL. The inhibitory action of iodide upon organic binding of iodine by the normal thyroid gland. J Biol Chem. 1948;172(2):855.

Markou K, Georgopoulos N, Kyriazopoulou V, et al. Iodine-Induced hypothyroidism. Thyroid. 2001;11(5):501-10.

Becks G, Eggo C, Burrow N. Regulation of differentiated thyroid function by iodide: preferential inhibitory effect of excess iodide on thyroid hormone secretion in sheep thyroid cell cultures. Endocrinology. 1987;120(6):2569-75.

Lamas L, Ingbar S. The effect of varying iodine content on the susceptibility of thyroglobulin to hydrolysis by thyroid acid protease. Endocrinology. 1978;102(1):188-97.

Nimmons G, Funk G, Graham M. Urinary iodine excretion after contrast computed tomography scan: implications for radioactive iodine use. JAMA Otolaryngology–Head & Neck Surgery. 2013;139(5):479-82.

Padovani P, Kasamatsu T, Nakabashi C. One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy. Thyroid. 2012;22(9):926-30.

Tintinalli JE. Acil Tıp Kapsamlı Bir Çalışma Klavuzu. (Serkan Emre EROĞLU, Çev. Ed.). İstanbul: Nobel Tıp Kitabevleri;2022.

Webb J, Thomsen H, Morcos S. The use of iodinated and gadolinium contrast media during pregnancy and lactation. European radiology. 2015;15(6):1234-40.

Atwell T, Lteif A, Brown D. Neonatal thyroid function after administration of IV iodinated contrast agent to 21 pregnant patients. American journal of roentgenology-new series. 2008;191(1):268.

McClennan B. Preston M. Hickey memorial lecture. Ionic and nonionic iodinated contrast media: evolution and strategies for use. American journal of roentgenology. 1990;155(2):225-33.

Solomon R, Brigorui C, Betmann M. Selection of contrast media. Kidney İnternational Supplement. 2006;100:35-45.

Bottinor W, Polkampally P, Jovin I. Adverse reactions to iodinated contrast media. International Journal of Angiology. 2013;22(3):149-54.

Pacheco FJ, Vidal B, Mendez C. Extravasation of contrast media at the puncture site: Strategies for managment. Radiologia. 2014;56(4):295-302.

Rhee C, Lynch K. Iodinated Contrast Media Exposure and Incident Hyperthyroidism and Hypothyroidism in a Community-Based Cohort. Endocrinology Studies. 2013;3(8):27-30.

Ozkan S, Oysu AS, Kayatas K. Thyroid functions after contrast agent administration for coronary angiography: a prospective observational study in euthyroid patients. Anatolian Journal of Cardiology. 2013;13(4):363-369.

Dineen R, Thompson J, Sherlock M. Adrenal crisis: prevention and management in adult patients. Therapeutic Advences Endocrinology and Metabolism. 2019;10:1-12.

Roti E, Uberti E. Iodine excess and hyperthyroidism. Official Journal of The American Thyroid Association. 2001;11(5):493-500.

Muller R, Siggelkow H, Emrich D. Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study. European Journal of Endocrinology. 1996;134(3):337-341.

Braverman L, Woeber K, Ingbar S. Induction of myxedema by iodide in patients euthyroid after radioiodin or surgical treatment of diffuse toxic goiter. The New England Journal of Medicine. 1969;281(15):816-21.

Braverman L, Ingbar S, Vagenakis AG. Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease. The Journa of Clinical Endocrinology and Metabolism. 1971;32(4):515-21.

Wilson S, Stem L, Bruehlman R. Hypothyroidism: Diagnosis and Treatment. American Family Physcian. 2021;103(10):605-13.

Braverman L. Effects of iodine on thyroid function in man. Transaction of The American Clinical and ClimatologicalAssociation. 1991;102:143-51.

Thaker V, Leung A, Braverman L. Iodine-induced hypothyroidism in full-term infants with congenital heart disease: more common than currently appreciated. The Journa of Clinical Endocrinology and Metabolism. 2014;99(10):3521-3526.

Lal A, Kaur N, Trivedi N. Metformin, arterial contrast and acute kidney Injury. Acta Biomedica. 2019;90(2)355-356.

Pokhrel A, Tun M, Miah S. A Thyrotoxicosis Surprise: Jod-Basedow Phenomenon Following IV Contrast Administration. Cureus. 2022;14(5):1-3.

Bourin M, Jolliet P. An overview of the clinical pharmacokinetics of x-ray contrast media. Clinical Pharmocokinetics. 1997;32(3):180-93.

Meurer K, Kelsch B, Hogstrom B. The pharmacokinetic profile, tolerability and safety of the iodinated, non-ionic, dimeric contrast medium Iosimenol 340 injection in healthy human subjects. Acta radyologica. 2015;56(5):581-86.

Geenen RW, Kingma HJ, van der Molen AJ. Contrast-induced nephropathy: pharmacology, pathophysiology and prevention. Insights Imaging. 2013;4(6):811-20.

Krause D, Marycz D, Ziada KM. Nonrenal Complications of Contrast Media. Interventional Cardiology Clinics. 2020;9(3):311-9.

Nielsen Y, Thomsen H. Trends in contrast media research the last 100 years. Acta radyologica. 2021;62(11):1515-24.

Wolff J, Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem. 1948;174(2):555-64.

Lee SY, Rhee CM, Leung AM, et al. A review: radiographic iodinated contrast media-induced thyroid dysfunction. The Journal of Clinical Endocrinology & Metabolism. 2015;100(2):376-83.

Wolff J, Chaikoff IL. The inhibitory action of iodide upon organic binding of iodine by the normal thyroid gland. J Biol Chem. 1948;172(2):855.

Markou K, Georgopoulos N, Kyriazopoulou V, et al. Iodine-Induced hypothyroidism. Thyroid. 2001;11(5):501-10.

Becks G, Eggo C, Burrow N. Regulation of differentiated thyroid function by iodide: preferential inhibitory effect of excess iodide on thyroid hormone secretion in sheep thyroid cell cultures. Endocrinology. 1987;120(6):2569-75.

Lamas L, Ingbar S. The effect of varying iodine content on the susceptibility of thyroglobulin to hydrolysis by thyroid acid protease. Endocrinology. 1978;102(1):188-97.

Nimmons G, Funk G, Graham M. Urinary iodine excretion after contrast computed tomography scan: implications for radioactive iodine use. JAMA Otolaryngology–Head & Neck Surgery. 2013;139(5):479-82.

Padovani P, Kasamatsu T, Nakabashi C. One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy. Thyroid. 2012;22(9):926-30.

Tintinalli JE. Acil Tıp Kapsamlı Bir Çalışma Klavuzu. (Serkan Emre EROĞLU, Çev. Ed.). İstanbul: Nobel Tıp Kitabevleri;2022.

Webb J, Thomsen H, Morcos S. The use of iodinated and gadolinium contrast media during pregnancy and lactation. European radiology. 2015;15(6):1234-40.

Atwell T, Lteif A, Brown D. Neonatal thyroid function after administration of IV iodinated contrast agent to 21 pregnant patients. American journal of roentgenology-new series. 2008;191(1):268.

McClennan B. Preston M. Hickey memorial lecture. Ionic and nonionic iodinated contrast media: evolution and strategies for use. American journal of roentgenology. 1990;155(2):225-33.

Solomon R, Brigorui C, Betmann M. Selection of contrast media. Kidney İnternational Supplement. 2006;100:35-45.

Bottinor W, Polkampally P, Jovin I. Adverse reactions to iodinated contrast media. International Journal of Angiology. 2013;22(3):149-54.

Pacheco FJ, Vidal B, Mendez C. Extravasation of contrast media at the puncture site: Strategies for managment. Radiologia. 2014;56(4):295-302.

Rhee C, Lynch K. Iodinated Contrast Media Exposure and Incident Hyperthyroidism and Hypothyroidism in a Community-Based Cohort. Endocrinology Studies. 2013;3(8):27-30.

Ozkan S, Oysu AS, Kayatas K. Thyroid functions after contrast agent administration for coronary angiography: a prospective observational study in euthyroid patients. Anatolian Journal of Cardiology. 2013;13(4):363-369.

Dineen R, Thompson J, Sherlock M. Adrenal crisis: prevention and management in adult patients. Therapeutic Advences Endocrinology and Metabolism. 2019;10:1-12.

Roti E, Uberti E. Iodine excess and hyperthyroidism. Official Journal of The American Thyroid Association. 2001;11(5):493-500.

Muller R, Siggelkow H, Emrich D. Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study. European Journal of Endocrinology. 1996;134(3):337-341.

Braverman L, Woeber K, Ingbar S. Induction of myxedema by iodide in patients euthyroid after radioiodin or surgical treatment of diffuse toxic goiter. The New England Journal of Medicine. 1969;281(15):816-21.

Braverman L, Ingbar S, Vagenakis AG. Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease. The Journa of Clinical Endocrinology and Metabolism. 1971;32(4):515-21.

Wilson S, Stem L, Bruehlman R. Hypothyroidism: Diagnosis and Treatment. American Family Physcian. 2021;103(10):605-13.

Braverman L. Effects of iodine on thyroid function in man. Transaction of The American Clinical and ClimatologicalAssociation. 1991;102:143-51.

Thaker V, Leung A, Braverman L. Iodine-induced hypothyroidism in full-term infants with congenital heart disease: more common than currently appreciated. The Journa of Clinical Endocrinology and Metabolism. 2014;99(10):3521-3526.

Lal A, Kaur N, Trivedi N. Metformin, arterial contrast and acute kidney Injury. Acta Biomedica. 2019;90(2)355-356.

Pokhrel A, Tun M, Miah S. A Thyrotoxicosis Surprise: Jod-Basedow Phenomenon Following IV Contrast Administration. Cureus. 2022;14(5):1-3.